Nevro to Present at Truist Securities MedTech Conference

Company Overview - Nevro Corp. is a global medical device company headquartered in Redwood City, California, focused on chronic pain treatment solutions [1] - The company has developed the proprietary 10 kHz Therapy™, which has positively impacted over 115,000 patients worldwide [1] Product Offerings - Nevro's HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system and services for treating chronic pain and painful diabetic neuropathy [1] - The company recently introduced a minimally invasive treatment option for chronic sacroiliac joint pain, expanding its product portfolio in the SI joint fusion space [9] Investor Engagement - Nevro's management team will participate in a "fireside chat" at the Truist Securities MedTech Conference on June 18, 2024, at approximately 8:40 am EDT [7] - The company encourages investors to regularly check its website for important updates and information [8]